口腔微生物与炎症性肠病的关系

doi:10.7518/hxkq.2019.04.020

华西口腔医学杂志 ›› 2019, Vol. 37 ›› Issue (4): 443-449.doi: 10.7518/hxkq.2019.04.020

口腔微生物与炎症性肠病的关系

张浩楠¹,周学东¹,徐欣¹,王艳²()

1.口腔疾病研究国家重点实验室国家口腔疾病临床医学研究中心四川大学华西口腔医院牙体牙髓病科
2.口腔疾病研究国家重点实验室国家口腔疾病临床医学研究中心四川大学华西口腔医院儿童口腔科,成都 610041

收稿日期:2018-03-20 修回日期:2019-04-18 出版日期:2019-08-01 发布日期:2019-08-23
通讯作者: 王艳 E-mail:wangyan1458@163.com
作者简介:张浩楠,住院医师,硕士,E-mail：452869433@qq.com
基金资助:
国家自然科学基金(81600864);国家自然科学基金(81771099);国家自然科学基金(81670978);四川省科技厅重大前沿项目(2016JY0006)

Oral microbiota and inflammatory bowel disease

Haonan Zhang¹,Xuedong Zhou¹,Xin Xu¹,Yan Wang²()

1.State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
2.State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China

Received:2018-03-20 Revised:2019-04-18 Online:2019-08-01 Published:2019-08-23
Contact: Yan Wang E-mail:wangyan1458@163.com
Supported by:
The National Natural Science Foundation of China(81600864);The National Natural Science Foundation of China(81771099);The National Natural Science Foundation of China(81670978);Foundation of the Science and Technology Department of Sichuan Province(2016JY0006)

摘要/Abstract

摘要：

炎症性肠病（IBD）是一种发病率高但治疗效果欠佳的特发性肠道炎症性疾病。目前认为IBD是环境因素、肠道菌群、个体易感性之间复杂作用的结果。近年来鉴于IBD患者的一系列口腔表征以及口腔微生物在IBD患者体内的高检出率,不少学者认为口腔微生物可能在IBD的发生发展中扮演了重要角色。本文就口腔微生物与IBD的关系研究进展作一综述。

关键词: 炎症性肠病, 口腔微生物, 溃疡性结肠炎, 克隆恩病

Abstract:

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract with a high incidence but a poor therapeutic outcome. However, IBD is generally caused by complicated interactions between environmental factors and gut microflora in genetically susceptible individuals. In view of a series of oral manifestations in patients with IBD and a high detection rate of oral bacteria among this population, oral microbiota may play an important role in the development of IBD. This article reviews the relationship between oral microbiota and IBD.

Key words: inflammatory bowel disease, oral microbiota, ulcerative colitis, Crohn’s disease;

中图分类号:

R780.2

张浩楠,周学东,徐欣,王艳. 口腔微生物与炎症性肠病的关系[J]. 华西口腔医学杂志, 2019, 37(4): 443-449.

Haonan Zhang,Xuedong Zhou,Xin Xu,Yan Wang. Oral microbiota and inflammatory bowel disease[J]. West China Journal of Stomatology, 2019, 37(4): 443-449.

参考文献 67

[1]	Malik TA . Inflammatory bowel disease: historical perspective, epidemiology, and risk factors[J]. Surg Clin North Am, 2015,95(6):1105-1122.
[2]	Molodecky NA, Soon IS, Rabi DM , et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review[J]. Gastroenterology, 2012,142(1):46-54.
[3]	Mulder DJ, Noble AJ, Justinich CJ , et al. A tale of two diseases: the history of inflammatory bowel disease[J]. J Crohns Colitis, 2014,8(5):341-348.
[4]	Zhang YZ, Li YY . Inflammatory bowel disease: pathogenesis[J]. World J Gastroenterol, 2014,20(1):91-99.
[5]	Adams SM, Bornemann PH . Ulcerative colitis[J]. Am Fam Physician, 2013,87(10):699-705.
[6]	Jostins L, Ripke S, Weersma RK , et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease[J]. Nature, 2012,491(7422):119-124.
[7]	张静, 韩英, 王继恒 , 等. 炎症性肠病与肠道细菌研究进展[J]. 世界华人消化杂志, 2007,15(12):1406-1410.
	Zhang J, Han Y, Wang JH , et al. Advance on the relationship between inflammatory bowel disease and intestinal bacteria[J]. World Chin J Digestol, 2007,15(12):1406-1410.
[8]	白爱平 . 炎症性肠病发病机制的微生物因素[J]. 世界华人消化杂志, 2006,14(7):645-649.
	Bai AP . Biological factors in pathogenesis of inflammatory bowel disease[J]. World Chin J Digestol, 2006,14(7):645-649.
[9]	Scaldaferri F, Gerardi V, Lopetuso LR , et al. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility[J]. Biomed Res Int, 2013,2013:435268.
[10]	Willing BP, Dicksved J, Halfvarson J , et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes[J]. Gastroenterology, 2010,139(6):1844-1854.
[11]	Maloy KJ, Powrie F . Intestinal homeostasis and its breakdown in inflammatory bowel disease[J]. Nature, 2011,474(7351):298-306.
[12]	牛润章, 张兰兰, 司依馨 . 炎症性肠病的病因及诊治研究进展[J]. 实用医药杂志, 2014,31(5):461-463.
	Niu RZ, Zhang LL, Si YX . Etiology, diagnosis and treatment of inflammatory bowel disease[J]. Pract J Med Pharm, 2014,31(5):461-463.
[13]	Yang Y, Weng W, Peng J , et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of MicroRNA-21[J]. Gastroenterology, 2017,152(4):851-866.
[14]	Bashir A, Miskeen AY, Bhat A , et al. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis[J]. Eur J Cancer Prev, 2015,24(5):373-385.
[15]	Gur C, Ibrahim Y, Isaacson B , et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J]. Immunity, 2015,42(2):344-355.
[16]	Bashir A, Miskeen AY, Hazari YM , et al. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut[J]. Tumour Biol, 2016,37(3):2805-2810.
[17]	Rogers MB, Brower-Sinning R, Firek B , et al. Acute appendicitis in children is associated with a local expansion of fusobacteria[J]. Clin Infect Dis, 2016,63(1):71-78.
[18]	Guinane CM, Tadrous A, Fouhy F , et al. Microbial composition of human appendices from patients following appendectomy[J]. MBio, 2013, 4(1). pii:e00366-12. doi: 10.1128/mBio.00366-12.
[19]	Singhal S, Dian D, Keshavarzian A , et al. The role of oral hygiene in inflammatory bowel disease[J]. Dig Dis Sci, 2011,56(1):170-175.
[20]	Habashneh RA, Khader YS, Alhumouz MK , et al. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study[J]. J Periodontal Res, 2012,47(3):293-298.
[21]	Ricart E, Panaccione R, Loftus EV Jr , et al. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study[J]. Inflamm Bowel Dis, 2004,10(3):207-214.
[22]	Veloso FT, Carvalho J, Magro F . Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients[J]. J Clin Gastroenterol, 1996,23(1):29-34.
[23]	Lakatos L, Pandur T, David G , et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study[J]. World J Gastroenterol, 2003,9(10):2300-2307.
[24]	Muhvić-Urek M, Tomac-Stojmenović M, Mijandrušić-Sinčić B . Oral pathology in inflammatory bowel disease[J]. World J Gastroenterol, 2016,22(25):5655-5657.
[25]	Mills CC, Amin M, Manisali M . Salivary duct fistula and recurrent buccal space infection: a complication of Crohn’s disease[J]. J Oral Maxillofac Surg, 2003,61(12):1485-1487.
[26]	李敏, 宋文婷, 林梅 , 等. 炎症性肠病的口腔损害及其诊断[J]. 国际口腔医学杂志, 2010,37(3):330-332. doi: 10.3969/j.issn.1673-5749.2010.
	Li M, Song WT, Lin M , et al. Oral lesion of inflammatory bowel disease and its diagnosis[J]. Int J Stomatol, 2010,37(3):330-332. doi: 10.3969/j.issn.1673-5749.2010.
[27]	Lankarani KB, Sivandzadeh GR, Hassanpour S . Oral manifestation in inflammatory bowel disease: a review[J]. World J Gastroenterol, 2013,19(46):8571-8579.
[28]	Said HS, Suda W, Nakagome S , et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers[J]. DNA Res, 2014,21(1):15-25.
[29]	Szczeklik K, Owczarek D, Pytko-Polończyk J , et al. Proinflammatory cytokines in the saliva of patients with active and non-active Crohn’s disease[J]. Pol Arch Med Wewn, 2012,122(5):200-208.
[30]	Rathnayake N, Åkerman S, Klinge B , et al. Salivary biomarkers for detection of systemic diseases[J]. PLoS One, 2013,8(4):e61356.
[31]	Wescombe PA, Hale JD, Heng NC , et al. Developing oral probiotics from Streptococcus salivarius[J]. Future Microbiol, 2012,7(12):1355-1371.
[32]	Teughels W, Kinder Haake S, Sliepen I , et al. Bacteria interfere with A. actinomycetemcomitans colonization[J]. J Dent Res, 2007,86(7):611-617.
[33]	Kaci G, Lakhdari O, Doré J , et al. Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius[J]. Appl Environ Microbiol, 2011,77(13):4681-4684.
[34]	Cosseau C, Devine DA, Dullaghan E , et al. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis[J]. Infect Immun, 2008,76(9):4163-4175.
[35]	Kaci G, Goudercourt D, Dennin V , et al. Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract[J]. Appl Environ Microbiol, 2014,80(3):928-934.
[36]	Fujiwara T, Nakano K, Kawaguchi M , et al. Biochemical and genetic characterization of serologically untypable Streptococcus mutans strains isolated from patients with bacteremia[J]. Eur J Oral Sci, 2001,109(5):330-334.
[37]	Nakano K, Nomura R, Nakagawa I , et al. Demonstration of Streptococcus mutans with a cell wall polysaccharide specific to a new serotype, k, in the human oral cavity[J]. J Clin Microbiol, 2004,42(1):198-202.
[38]	Kojima A, Nakano K, Wada K , et al. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis[J]. Sci Rep, 2012,2:332.
[39]	Kojima A, Nomura R, Naka S , et al. Aggravation of inflammatory bowel diseases by oral streptococci[J]. Oral Dis, 2014,20(4):359-366.
[40]	Liu P, Liu Y, Wang J , et al. Detection of Fusobacterium nucleatum and fadA adhesin gene in patients with orthodontic gingivitis and non-orthodontic periodontal inflammation[J]. PLoS One, 2014,9(1):e85280.
[41]	Nosho K, Sukawa Y, Adachi Y , et al. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer[J]. World J Gastroenterol, 2016,22(2):557-566.
[42]	Strauss J, Kaplan GG, Beck PL , et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host[J]. Inflamm Bowel Dis, 2011,17(9):1971-1978.
[43]	Liu H, Redline RW, Han YW . Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response[J]. J Immunol, 2007,179(4):2501-2508.
[44]	Kostic AD, Chun E, Robertson L , et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment[J]. Cell Host Microbe, 2013,14(2):207-215.
[45]	Sears CL, Garrett WS . Microbes, microbiota, and colon cancer[J]. Cell Host Microbe, 2014,15(3):317-328.
[46]	Irrazábal T, Belcheva A, Girardin SE , et al. The multifaceted role of the intestinal microbiota in colon cancer[J]. Mol Cell, 2014,54(2):309-320.
[47]	Zhang L, Budiman V, Day AS , et al. Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease[J]. J Clin Microbiol, 2010,48(8):2965-2967.
[48]	Nielsen HL, Ejlertsen T, Engberg J , et al. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study[J]. Clin Microbiol Infect, 2013,19(5):445-450.
[49]	Mukhopadhya I, Thomson JM, Hansen R , et al. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis[J]. PLoS One, 2011,6(6):e21490.
[50]	Underwood AP, Kaakoush NO, Sodhi N , et al. Campylobacter concisus pathotypes are present at significant levels in patients with gastroenteritis[J]. J Med Microbiol, 2016,65(3):219-226.
[51]	Man SM, Kaakoush NO, Leach ST , et al. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species[J]. J Infect Dis, 2010,202(12):1855-1865.
[52]	Kalischuk LD, Inglis GD . Comparative genotypic and pathogenic examination of Campylobacter concisus isolates from diarrheic and non-diarrheic humans[J]. BMC Microbiol, 2011,11:53.
[53]	Ismail Y, Lee H, Riordan SM , et al. The effects of oral and enteric Campylobacter concisus strains on expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 cells[J]. PLoS One, 2013,8(2):e56888.
[54]	Nielsen HL, Nielsen H, Ejlertsen T , et al. Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells[J]. PLoS One, 2011,6(8):e23858.
[55]	Zhang L, Lee H, Grimm MC , et al. Campylobacter concisus and inflammatory bowel disease[J]. World J Gastroenterol, 2014,20(5):1259-1267.
[56]	Waldor MK, Mekalanos JJ . Lysogenic conversion by a filamentous phage encoding cholera toxin[J]. Science, 1996,272(5270):1910-1914.
[57]	Fasano A, Baudry B, Pumplin DW , et al. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions[J]. Proc Natl Acad Sci U S A, 1991,88(12):5242-5246.
[58]	Kaakoush NO, Mitchell HM, Man SM . Role of emerging Campylobacter species in inflammatory bowel diseases[J]. Inflamm Bowel Dis, 2014,20(11):2189-2197.
[59]	王林峰, 王选锭 . 肺炎克雷伯氏菌耐药机制研究进展[J]. 中国抗生素杂志, 2004,29(6):324-328.
	Wang LF, Wang XD . Advances in the mechanism of drug resistance of Klebsiella pneumoniae[J]. Chin J Antibiot, 2004,29(6):324-328.
[60]	Pamer EG . Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens[J]. Science, 2016,352(6285):535-538.
[61]	Atarashi K, Suda W, Luo C , et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation[J]. Science, 2017,358(6361):359-365.
[62]	Cao XT . Intestinal inflammation induced by oral bacteria[J]. Science, 2017,358(6361):308-309.
[63]	Inohara N . Route connection: mouth to intestine in colitis[J]. Cell Host Microbe, 2017,22(6):730-731.
[64]	Poulain D . Candida albicans, plasticity and pathogenesis[J]. Crit Rev Microbiol, 2015,41(2):208-217.
[65]	Standaertvitse A, Sendid B, Joossens M , et al. Candida albicans colonization and ASCA in familial Crohn’s disease[J]. Am J Gastroenterol, 2009,104(7):1745-1753.
[66]	Zwolinska-Wcislo M, Brzozowski T, Budak A , et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa[J]. J Physiol Pharmacol, 2009,60(1):107-118.
[67]	Forcione DG, Rosen MJ, Kisiel JB , et al. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn’s disease[J]. Gut, 2004,53(8):1117-1122.

口腔微生物与炎症性肠病的关系

Oral microbiota and inflammatory bowel disease

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 67

相关文章 15

编辑推荐

Metrics

本文评价

[1]	阮敏慧, 王冏珂, 曾昕. 以单侧颊部局限性肿胀为首发主要表现的增殖性化脓性口炎1例[J]. 华西口腔医学杂志, 2023, 41(1): 99-103.
[2]	宗雅文, 程磊, 郭强, 周学东, 任彪. 中药酚性化合物对口腔微生物调节作用的研究进展[J]. 华西口腔医学杂志, 2020, 38(3): 319-323.
[3]	周祉延,徐欣,周媛. 人体微生物碳水化合物活性酶的研究进展[J]. 华西口腔医学杂志, 2019, 37(6): 666-670.
[4]	刘云坤,徐欣,周学东. 人体微生物组在辅助2型糖尿病诊疗中的潜在应用[J]. 华西口腔医学杂志, 2019, 37(5): 556-562.
[5]	李博磊, 程磊, 周学东, 彭显. 口腔微生物与消化系统疾病关系的研究进展[J]. 华西口腔医学杂志, 2018, 36(3): 331-335.
[6]	陈婧, 程磊, 周学东, 彭显. 龋病微生物因素研究进展[J]. 华西口腔医学杂志, 2018, 36(1): 104-108.
[7]	章可可, 周学东, 徐欣. 口腔中过氧化氢的来源及在微生态平衡中的作用[J]. 华西口腔医学杂志, 2017, 35(2): 215-220.
[8]	谢美莲余挺卓颖黄馨谢宝仪轩东英章锦才. 牙周局部炎症影响小鼠肠道机械及免疫屏障功能[J]. 华西口腔医学杂志, 2016, 34(4): 414-418.
[9]	徐欣,何金枝,周学东. 口腔微生物群落在口腔与全身疾病预警中的作用[J]. 华西口腔医学杂志, 2015, 33(6): 555-560.
[10]	朱彦杨靖梅段丁瑜徐屹. 口腔微生物生物膜分散物质的研究进展[J]. 华西口腔医学杂志, 2014, 32(6): 625-630.
[11]	葛阳程磊周学东. 口腔微生物与肿瘤关系的研究进展[J]. 华西口腔医学杂志, 2014, 32(5): 527-531.
[12]	杜芹王艳徐欣李雨庆李明云邹静周学东. 双生子儿童口腔微生物群组结构分析[J]. 华西口腔医学杂志, 2014, 32(2): 182-185.
[13]	邓盟齐霞徐欣周学东. 人体口腔微生物宏基因组的研究进展[J]. 华西口腔医学杂志, 2013, 31(1): 107-111.
[14]	邱瑜蕾周学东包崇云. 微结构芯片对石墨粉吸附及3种口腔微生物黏附行为的影响[J]. 华西口腔医学杂志, 2011, 29(03): 323-326.
[15]	周学东施文元. 人体口腔微生物组群与牙菌斑生物膜[J]. 华西口腔医学杂志, 2010, 28(02): 115-118.